| Name | Hanger Clinic |
|---|---|
| Organization Name | Hanger Prosthetics & Orthotics Inc |
| Location | 2051 N Bridge St, Chillicothe, Ohio 45601 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (740) 773-4021 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
Advances in neuroscience and engineering have generated great hope for Luke Skywalker-like prosthetics: robotic devices that are almost indistinguishable from a human limb.
Research published in the October 2009 issue of the Journal of Thoracic Oncology has found an effective combination of positron emission tomography (PET)/computed tomography (CT) (PET/CT) tests to diagnose lung cancer in a "fast-tracked" outpatient setting. This novel approach to the diagnosis of lung cancer demonstrated a high level of sensitivity (97%) and accuracy (82%).
Head and neck cancer is one of the leading causes of cancer-related deaths worldwide, and squamous cell carcinomas (HNSCC) account for the majority of these cases.
› Verified 7 days ago
| NPI Number | 1578637617 |
| Organization Name | HANGER PROSTHETICS & ORTHOTICS INC |
| Doing Business As | HANGER CLINIC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2051 N Bridge St, Chillicothe, OH 45601 |
| Phone Number | 740-773-4021 |
News Archive
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
Advances in neuroscience and engineering have generated great hope for Luke Skywalker-like prosthetics: robotic devices that are almost indistinguishable from a human limb.
Research published in the October 2009 issue of the Journal of Thoracic Oncology has found an effective combination of positron emission tomography (PET)/computed tomography (CT) (PET/CT) tests to diagnose lung cancer in a "fast-tracked" outpatient setting. This novel approach to the diagnosis of lung cancer demonstrated a high level of sensitivity (97%) and accuracy (82%).
Head and neck cancer is one of the leading causes of cancer-related deaths worldwide, and squamous cell carcinomas (HNSCC) account for the majority of these cases.
› Verified 7 days ago
News Archive
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
Advances in neuroscience and engineering have generated great hope for Luke Skywalker-like prosthetics: robotic devices that are almost indistinguishable from a human limb.
Research published in the October 2009 issue of the Journal of Thoracic Oncology has found an effective combination of positron emission tomography (PET)/computed tomography (CT) (PET/CT) tests to diagnose lung cancer in a "fast-tracked" outpatient setting. This novel approach to the diagnosis of lung cancer demonstrated a high level of sensitivity (97%) and accuracy (82%).
Head and neck cancer is one of the leading causes of cancer-related deaths worldwide, and squamous cell carcinomas (HNSCC) account for the majority of these cases.
› Verified 7 days ago
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 440 Chamber Dr, Chillicothe, Ohio 45601 Phone: (740) 779-9390 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 95 N Bridge St, Chillicothe, Ohio 45601 Phone: (740) 286-7484 | |
Cvs Pharmacy #06190 Type: Medicare Supplier Location: 1021 N Bridge St, Chillicothe, Ohio 45601 Phone: (740) 702-1108 | |
Cvs Pharmacy #06189 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11 Centennial Blvd, Chillicothe, Ohio 45601 Phone: (740) 702-1100 | |
Walgreens #7799 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 850 N Bridge St, Chillicothe, Ohio 45601 Phone: (740) 779-2905 |